Feasibility Study on the Use of Redormin®500 on Day-time Cognition

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions

Sleep Disorders, Circadian RhythmCognitive Dysfunction

Interventions

DRUG

Valerian-Hop Extract

herbal drug

DRUG

Placebo

Trial Locations (1)

Research Platform MCN University of Basel, Basel

All Listed Sponsors

collaborator

University of Basel

OTHER

lead

Max Zeller Soehne AG

INDUSTRY